BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moiseev S, Kronbichler A, Makarov E, Bulanov N, Crnogorac M, Direskeneli H, Galesic K, Gazel U, Geetha D, Guillevin L, Hrušková Z, Little MA, Ahmed A, McAdoo SP, Mohammad AJ, Moran S, Novikov P, Pusey CD, Rahmattulla C, Satrapová V, Silva J, Terrier B, Tesař V, Westman K, Jayne DRW. Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study. Rheumatology (Oxford) 2021:keab071. [PMID: 33523099 DOI: 10.1093/rheumatology/keab071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Dammacco R, Biswas J, Mohanan-Earatt A, Lisch W, Zito FA, Rubini G, Manno C, Cicco S, Alessio G, Dammacco F. The eye is a common site of granulomatosis with polyangiitis. A collaborative study. BMC Ophthalmol 2023;23:26. [PMID: 36653761 DOI: 10.1186/s12886-022-02743-x] [Reference Citation Analysis]
2 Baier E, Tampe D, Kluge IA, Hakroush S, Tampe B. Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1054457] [Reference Citation Analysis]
3 Trivioli G, Marquez A, Martorana D, Tesi M, Kronbichler A, Lyons PA, Vaglio A. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management. Nat Rev Rheumatol. [DOI: 10.1038/s41584-022-00819-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Nevares A, Yaseen K, Tamaki H, Bena J, Messner W, Villa-forte A. Recurrence rate of venous thromboembolic events in granulomatosis with polyangiitis. Rheumatology Advances in Practice 2022;6. [DOI: 10.1093/rap/rkac058] [Reference Citation Analysis]
5 Austin K, Janagan S, Wells M, Crawshaw H, Mcadoo S, Robson JC. ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives. JIR 2022;Volume 15:2567-82. [DOI: 10.2147/jir.s284768] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Adachi S, Oshikata C, Kaneko T, Tsurikisawa N. Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi. Allergy Asthma Clin Immunol 2022;18:18. [PMID: 35219344 DOI: 10.1186/s13223-021-00639-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kronbichler A, Geetha D, Smith RM, Egan AC, Bajema IM, Schönermarck U, Mahr A, Anders HJ, Bruchfeld A, Cid MC, Jayne DRW. The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum. Autoimmun Rev 2021;20:102986. [PMID: 34718165 DOI: 10.1016/j.autrev.2021.102986] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
8 Karpman D, Tontanahal A. Extracellular vesicles in renal inflammatory and infectious diseases. Free Radic Biol Med 2021;171:42-54. [PMID: 33933600 DOI: 10.1016/j.freeradbiomed.2021.04.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Almaani S, Fussner LA, Brodsky S, Meara AS, Jayne D. ANCA-Associated Vasculitis: An Update. J Clin Med 2021;10:1446. [PMID: 33916214 DOI: 10.3390/jcm10071446] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]